CD Skripsi
Efek Inhibitor Proteasom Terhadap Histopatologi Aorta Torakalis Pada Tikus Model Aterosklerosis
Proteasomes are large protein complexes responsible for the degradation of
intracellular proteins other than lysosomes through the ubiquitin-proteasome
system. Previous studies have shown an increase in proteasome expression at
each stage of atherosclerosis, especially at the progression stage. This study aims
to analyxe the effects of proteasome inhibitor that is called bortezomib on
atheroclerosis lesion in the thoracic aorta of atherosclerosis models.This
experimental research uses 18 rats (rattus novergicus) male wistar strain that is
divided into control group (I), atherosclerosis group (II), and atherosclerosis with
bortezomib group (III). Atherosclerosis induction is done by giving vitamin D3
(700.000 IU/KgBB) orally by means of gastric intubation on day 1 and
atherogenic feed in the form of (2% cholesterol, 5% goat fat, 0.2% cholic acid)
for 4 days. Low doses of bortezomib (50 μg/kgBB)is given two times which is the
first and third day intraperitoneally. Thoracic aortic histopatological assessment
was carried out using a scoring system. The results showed that the highest mean
score of lesions was in the atherosclerosis group, namely 1.37 and the lowest in
the control group, namely 0.06. There was a decrease in the score of
atherosclerotic lesions with the administration of bortezomib with an average
score of 0.61, altough statistically it has not shown significant result.
Keywords: Atheroslerosis, Bortezomib, Proteasom, Thoracic Aorta
Tidak tersedia versi lain